148 related articles for article (PubMed ID: 17007651)
1. Interval breast cancers: prognostic features and survival by subtype and time since screening.
Porter GJ; Evans AJ; Burrell HC; Lee AH; Ellis IO; Chakrabarti J
J Med Screen; 2006; 13(3):115-22. PubMed ID: 17007651
[TBL] [Abstract][Full Text] [Related]
2. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
3. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.
Evans AJ; Rakha EA; Pinder SE; Green AR; Paish C; Ellis IO
J Med Screen; 2007; 14(4):210-4. PubMed ID: 18078567
[TBL] [Abstract][Full Text] [Related]
4. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of palpability as a feature of screen-detected breast cancers.
Gill G; Luke C; Roder D
J Med Screen; 2006; 13(2):98-101. PubMed ID: 16792834
[TBL] [Abstract][Full Text] [Related]
6. Interval breast cancer: is it a different type of breast cancer?
Raja MA; Hubbard A; Salman AR
Breast; 2001 Apr; 10(2):100-8. PubMed ID: 14965568
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
8. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
9. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
10. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
[TBL] [Abstract][Full Text] [Related]
11. Pathology characteristics that optimize outcome prediction of a breast screening trial.
Anderson TJ; Alexander FE; Lamb J; Smith A; Forrest AP
Br J Cancer; 2000 Aug; 83(4):487-92. PubMed ID: 10945496
[TBL] [Abstract][Full Text] [Related]
12. Reviewing interval cancers: time well spent?
Gower-Thomas K; Fielder HM; Branston L; Greening S; Beer H; Rogers C
Clin Radiol; 2002 May; 57(5):384-8. PubMed ID: 12014936
[TBL] [Abstract][Full Text] [Related]
13. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
14. Casting-type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients.
Pálka I; Ormándi K; Gaál S; Boda K; Kahán Z
Acta Oncol; 2007; 46(8):1178-83. PubMed ID: 17851833
[TBL] [Abstract][Full Text] [Related]
15. Distant metastasis after radical treatment of breast cancer: risk factors and their prognostic relevance in 378 consecutive patients.
Daskalova I; Popovska S; Betova T; Velkova A; Ivanova N; Baitchev G; Delijski T
J BUON; 2009; 14(2):229-33. PubMed ID: 19650171
[TBL] [Abstract][Full Text] [Related]
16. 'Blind' multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer.
Theissig F; Baak JP; Schuurmans L; Haroske G; Meyer W; Kunze KD
Anal Cell Pathol; 1996 Mar; 10(2):85-99. PubMed ID: 8721952
[TBL] [Abstract][Full Text] [Related]
17. Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival.
Jensen AR; Madsen AH; Overgaard J
Acta Oncol; 2008; 47(4):537-44. PubMed ID: 18465319
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of screen-detected breast cancers: results of a population based study.
Cortesi L; Chiuri VE; Ruscelli S; Bellelli V; Negri R; Rashid I; Cirilli C; Fracca A; Gallo E; Federico M
BMC Cancer; 2006 Jan; 6():17. PubMed ID: 16430776
[TBL] [Abstract][Full Text] [Related]
19. The clinical and pathological differences in prevalent round screen-detected and symptomatic invasive breast cancer.
Sweeney KJ; Kell MR; Aziz NA; Prunty N; Holloway P; Kennedy M; Flanagan F; Kerin MJ
Ir Med J; 2007 Sep; 100(8):550-2. PubMed ID: 17955686
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of necrosis in Nigerian breast cancer.
Ikpatt O; Ndoma-Egba R; Collan Y
Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
